News Coverage 10.22.19 By: Molika Ashford Share on Twitter Share on Facebook Share on LinkedIn Q&A: The Parker Institute’s Theresa LaVallee on the Path Forward for Precision Immuno-Oncology Related Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat